Pretreatment SUVmax as a Marker for Progression-Free Survival in Stage I NSCLC Treated With SBRT.
Horne ZD, Clump DA, Shah S, Vargo JA, Burton SA, Christie NA, Schuchert MJ, Landreneau RJ, Luketich JD, Heron DE.
Horne ZD, et al. Among authors: vargo ja.
Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S3-4. doi: 10.1016/j.prro.2013.01.014. Epub 2013 Mar 25.
Pract Radiat Oncol. 2013.
PMID: 24674539
No abstract available.